We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

13 hedge funds and large institutions have $340K invested in NeuroMetrix, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $227K → $340K (+$113K)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

7% less funds holding

Funds holding: 14 → 13 (-1)

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cerity Partners
Cerity Partners
New York
+$126K
2
Renaissance Technologies
Renaissance Technologies
New York
+$82.7K
3
VF
Virtu Financial
New York
+$50.9K
4
Osaic Holdings
Osaic Holdings
Arizona
+$26.4K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.8K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$46K
2
Citadel Advisors
Citadel Advisors
Florida
-$20K
3
State Street
State Street
Massachusetts
-$12.9K
4
Northern Trust
Northern Trust
Illinois
-$7.92K
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$287

NURO Hedge Fund Activity: Q4 2023 in Review

13 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2023, worth a combined $340K — up 50% from $227K a quarter earlier.

Fund positioning in NURO was balanced in Q4 2023: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 3 trimmed.

The largest buyer was Cerity Partners, opening a new position worth an estimated $126K. The largest seller was Geode Capital Management, exiting entirely with an estimated $46K sold.

  • 13 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2023, down from 14 in Q3 2023.
  • Funds reported $340K of NeuroMetrix, Inc. Common Stock stock for Q4 2023, up 50% quarter-over-quarter.
  • 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2023 and 5 closed out, a net change of 0 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2023 was Cerity Partners, an estimated $126K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q4 2023 was Geode Capital Management, an estimated $46K sold.

Based on aggregated 13F filings for Q4 2023.